FDA approves generic version of Jazz Pharma's sleep disorder drug
January 17, 2017 at 17:16 PM EST
Jan 17 (Reuters) - The U.S. Food and Drug Administration said on Tuesday it had approved the first generic version of Xyrem, Jazz Pharmaceuticals Plc's drug to treat patients with a medical condition that causes excessive daytime sleepiness. (http://bit.ly/2jHzIS9)
